StemCells Inc Profile

0.02  3.85%
10 Days Price Trend
November 30, 2015

StemCells Inc Market Sensitivity

As returns on market increase, returns on owning StemCells Inc are expected to decrease by larger amounts. On the other hand, during market turmoil, StemCells Inc is expected to significantly outperform it.
One Month Beta |Analyze StemCells Inc Demand Trend
Check current 30 days StemCells Inc correlation with market (NYSE)
β = -2.4735
StemCells Inc Large Negative BetaStemCells Inc Beta Legend

StemCells Inc Market Cap Over Time

Key Fundamentals

StemCells Inc Against Markets

StemCells Inc Leadership

Martin McGlynn CEO, Director, Member of Strategic Transactions Committee, CEO of Stemcells California Inc and President of Stemcells California Inc
John Schwartz Independent Chairman of the Board, Ph.D
More Executives

StemCells Inc Diversification Suggestion

Use StemCells Inc to enhance returns of your portfolios. The stock experiences unexpected upward trend. Watch out for market signals. Check odds of StemCells Inc to be traded at $0.648 in 30 days

StemCells Inc Daily Price Distribution

The median price of StemCells Inc for the period between Sat, Oct 31, 2015 and Mon, Nov 30, 2015 is 0.46 with a coefficient of variation of 11.09. The daily time series for the period is distributed with a sample standard deviation of 0.05, arithmetic mean of 0.46, and mean deviation of 0.04. The Stock received some media coverage during the period.

StemCells Inc Summary

StemCells Inc [STEM] is traded on Nasdaq Capital Markets in USA. It is located in Newark, CA and employs 69 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 55.27 M. StemCells Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 108.81 M outstanding shares of which 2.79 M shares are at this time shorted by private and institutional investors with about 7.14 trading days to cover.

StemCells Inc Accumulated Other Comprehensive Income Over Time

Past Market
Performance (0 to 100)
Chance of
NameStemCells Inc
InstrumentUSA Stock
ExchangeNasdaq Capital Markets
Contact Number510 456 4000
Analyst ConsensusStrong Buy 4 Opinions
Risk-adjusted AdviceStrong Sell Under Valued
CurrencyUSD - US Dollar
DescriptionStemCells Inc. a biopharmaceutical company researches develops and commercializes cellbased therapeutics and related technologies for stem cellbased research and drug discovery and development. more

StemCells Inc Alerts

StemCells Inc appears to be very risky and stock price may revert if volatility continues
StemCells Inc has some characteristics of a very speculative penny stock
StemCells Inc has high likelihood to experience some financial distress in the next 2 years
The company reported previous year revenue of 971.08 K. Net Loss for the year was (37.56 M) with profit before overhead, payroll, taxes, and interest of 1.01 M.
STEMCELLS INC currently holds about 21.19 M in cash with (30.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2.
Latest headline from StemCells Inc 288.9 Potential Upside Now Implied by H.C. Wainwright

StemCells Inc Upcoming Events

Upcoming Quarterly ReportMarch 21, 2016
Next Earnings ReportMay 3, 2016

StemCells Inc Corporate Filings

Results of Operations and Financial Condition. Other Events. Financial Statements and Exhibits
Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year. Other Events
Other Events
Departure of Directors or Certain Offices; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Other Events. Financial Statements and Exhibits

StemCells Inc Corporate Reports

Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance

StemCells Inc Earnings Estimates

EPSEstimate Date
Quarterly Estimate-0.09March 21, 2016
StemCells Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
StemCells Inc Earnings Estimate  

StemCells Inc Analyst Recommendations

Target PriceConsensus AdviceNumber of Analysts
2.662Strong Buy4
StemCells Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
StemCells Inc Analyst Advice  

StemCells Inc Research Report

Get StemCells Inc research report. Reports are available in pdf format and contain fundamental information about the equity. Click Generate StemCells Inc report to view

StemCells Inc Pair Trading Analysis

Correlation analysis and pair trading evaluation for StemCells Inc and Gilead Sciences. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Macroaxis investing idea could easily outperform a given market if properly optimized
Explore Investing Ideas  

StemCells Inc Directors

Irving Weissman Director
Eric Bjerkholt Independent Director
R Greer Independent Director

StemCells Inc Fundamentals Correlation

StemCells Inc vs Competition

StemCells Inc November 30, 2015 Opportunity Range